LIVN livanova.com: שווי חברה להכנסות

LivaNova PLC develops medical devices while facing FDA oversight and product recall risks. The company's EV/Sales ratio helps filter out market noise, and the current value of 3228.80 reflects the real-time valuation. Neurostimulator patents and certifications protect the business from competitors. A flexible network of certified component suppliers eliminates dependence on individual vendors during final assembly.
LivaNova Corp - פילוחים אנליטיים ומדדי מפתח (LIVN)

This indicator compares the enterprise value (EV), including debt and subtracting cash, with annual sales to determine the market price per unit of revenue. By analyzing the EV/Sales valuation multiple in the context of LivaNova PLC (LIVN) neuromodulation systems and circulation devices, an investor can identify whether the asset is overbought or if its innovative potential is undervalued relative to current operating revenues.